News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ulthera To Present At Canaccord Genuity Medical Technology & Diagnostics Forum


11/14/2013 1:26:32 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MESA, AZ--(Marketwired - November 13, 2013) -

Ulthera, Inc. -- a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications -- today announced it will be participating in the 2013 Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14 at The Westin New York Grand Central in New York, NY.

Ulthera's presentation is scheduled for Thursday, November 14, 2013 at 2:00 pm EST.

About Ulthera
Ulthera, Inc. is a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top-tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ultherapy.com.


Media Contact:
Lindsey Karberg
Ulthera, Inc.
480.619.4069
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Ulthera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES